A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H–Binding Proteins and Implications for Vaccine Coverage in Different Age Groups. - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Pediatric Infectious Disease Journal Année : 2013

A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H–Binding Proteins and Implications for Vaccine Coverage in Different Age Groups.

Susan Hoiseth
  • Fonction : Auteur
Ellen Murphy
  • Fonction : Auteur
  • PersonId : 886120
Lubomira Andrew
  • Fonction : Auteur
Xin Wang
  • Fonction : Auteur
  • PersonId : 1011924
Laura York
  • Fonction : Auteur
Charles Tan
  • Fonction : Auteur
Kathrin U. Jansen
  • Fonction : Auteur
Annaliesa S. Anderson
  • Fonction : Auteur correspondant
  • PersonId : 1040436

Connectez-vous pour contacter l'auteur

Résumé

BACKGROUND: Recombinant vaccines containing factor H-binding protein (fHBP) have been developed for the purpose of protection from invasive meningococcal serogroup B disease. Neisseria meningitidis fHBP sequences can be divided into 2 genetically and immunologically distinct subfamilies (A and B); thus, cross protection is conferred within but not between subfamilies. A comprehensive understanding of fHBP epidemiology is required to accurately assess the potential vaccine impact when considering different vaccination implementation strategies. METHODS: Systematically collected invasive meningococcal serogroup B isolates from England, Wales, Northern Ireland, the United States, Norway, France and the Czech Republic were previously characterized for fHBP sequence. This study expanded the evaluation with additional meningococcal serogroup B disease isolates from Spain (n = 346) and Germany (n = 205). This expanded set (n = 1841), collected over a 6-year period (2001 to 2006), was evaluated for fHBP sequence and fHBP subfamily relative to patient age. RESULTS: All 1841 isolates contained fhbp. fHBP sequences from Spain and Germany fell within the previously described subfamilies, with 69% of isolates belonging to subfamily B and 31% to subfamily A; prevalent sequence variants were also similar. Stratification of data by age indicated that disease in infants <1 year of age was caused by a significantly higher proportion of isolates with fHBP subfamily A variants than that seen in adolescents and young adults 11-25 years (47.7% versus 19.5%, P < 0.0001, respectively). CONCLUSIONS: These observations highlight a difference in epidemiology of fHBP subfamilies in different age groups, with fHBP subfamily A strains causing more disease in vulnerable populations, such as infants, than in adolescents.

Dates et versions

pasteur-02089119 , version 1 (03-04-2019)

Identifiants

Citer

Susan Hoiseth, Ellen Murphy, Lubomira Andrew, Ulrich Vogel, Matthias Frosch, et al.. A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H–Binding Proteins and Implications for Vaccine Coverage in Different Age Groups.. Pediatric Infectious Disease Journal, 2013, 32 (10), pp.1096-1101. ⟨10.1097/INF.0b013e31829aa63b⟩. ⟨pasteur-02089119⟩

Collections

PASTEUR
100 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More